Filing Details

Accession Number:
0000902664-25-001020
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Woodline Partners
Company:
Protara Therapeutics Inc. (NASDAQ:TARA)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Woodline Partners LP 0 1,331,258 3.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Includes 478,098 shares of Common Stock issuable upon exercise of warrants.


SCHEDULE 13G


 
Woodline Partners LP
 
Signature:/s/ Erin Mullen
Name/Title:Erin Mullen, General Counsel & Chief Compliance Officer
Date:02/14/2025